Arcutis Invest Information

Arcutis Announces Key Roflumilast Cream Data for Young Children with Atopic Dermatitis Mar 11, 2024

Arcutis Biotherapeutics Announces Inducement Grants in Compliance with Nasdaq Rules Dec 3, 2023